- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
2.—(1) For regulation 6 paragraph (2) of the principal Regulations (prohibition of advertisements referring to specified diseases), there shall be substituted the following paragraph—
“(2) Paragraph (1) shall not be taken to prohibit a person from issuing an advertisement which is likely to lead to the use of a relevant medicinal product—
(a)for the purpose of the prevention of neural tube defects; or
(b)for the purpose of the treatment of
(i)the symptoms of sprains or strains, or
(ii)the pain or stiffness of rheumatic or non-serious arthritic conditions.”.
(2) In Schedule 1 to the principal Regulations (diseases in respect of which advertisements to the public are prohibited), after the entry “Genetic disorders” there shall be inserted the entry “Joint, rheumatic and collagen diseases”.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include: